Author: France 24

They burst onto the scene four years ago and are taking over the pharmaceutical world. New GLP-1-based drugs like Ozempic, Wegovy or Zepbound are said to be a weight-loss game changer and could drive big pharma’s revenue for years to come. But they come with a hefty price tag, while some 50 to 70 percent of people taking GLP-1s suffer side effects. Charles Pellegrin asks Frederic Bizard, a health economist and professor at ESCP Business School, who has the most to gain from this pharma revolution.

Read More

A walkout by French air traffic controllers is causing major disruptions to summer travel, impacting not just French airports but also the country’s airspace. The US House of Representatives has passed Donald Trump’s sweeping budget bill, stripping millions of Americans of food benefits. Plus, France’s antitrust agency is fining fast-fashion retailer Shein €40 million for deceptive business practices.

Read More

A Strasbourg court has authorised the permanent containment of approximately 42,000 tonnes of highly toxic chemical waste: cyanide, arsenic, mercury, and more, at the former Stocamine potash mine. France is set to inject concrete and seal the mine galleries to protect Europe’s largest aquifer. Geological subsidence, heat-induced rock shifts, and corroding barriers raise fears of eventual leakage into the Upper Rhine aquifer, which supplies drinking water to millions across France, Germany, and Switzerland. For in-depth analysis and a deeper perspective on this veritable “timebomb for future generations”, FRANCE 24’s Eve Irvine welcomes Marcos Buser, Geologist and Social Scientist.

Read More

Report shows recent heatwaves across Europe could slow economic growth by half a percentage point in 2025. But first, US President Donald Trump announces a trade deal with Vietnam. Plus, a French court has sentenced three former Ubisoft executives to suspended jail terms for harassment at the company.

Read More